Catastrophic Merkel Cell Carcinoma in a Liver Transplant Recipient.

Rabab S Isa, Emily Clarke, Hanna Fanous, Anokhi Jambusaria-Pahlajani

Open access · diamondAbstract readCase Reports

In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 55% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rabab S IsaDepartment of Internal Medicine, Division of Dermatology, Dell Medical School at the University of Texas at Austin, Austin, USA.

Emily ClarkeDepartment of Internal Medicine, Division of Dermatology, Dell Medical School at the University of Texas at Austin, Austin, USA.

Hanna FanousDepartment of Internal Medicine, Division of Dermatology, Dell Medical School at the University of Texas at Austin, Austin, USA.

Anokhi Jambusaria-PahlajaniDepartment of Internal Medicine, Division of Dermatology, Dell Medical School at the University of Texas at Austin, Austin, USA.

The University of Texas at Austin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Merkel cell carcinoma (MCC) is a rare skin cancer, is difficult to diagnose, and carries a high mortality rate. Solid organ transplant recipients (SOTR) are at a disproportionately increased risk of MCC and other malignancies due to chronic immunosuppression. We discuss the case of a 47-year-old woman with a remote history of liver transplant on chronic immunosuppression with tacrolimus for over a decade who presented for a third recurrence of MCC on her left forearm. This case report underscores the importance of a risk-stratified approach to regular dermatologic care and skin cancer screening in this vulnerable population.

Indexed as

calcineurin inhibitorimmunosuppressionmerkel cell carcinomamtor inhibitornmsc(nonmelanoma skin cancer )skin cancertransplant

Identifiers

PMID37842425

DOI10.7759/cureus.45133

PMCPMC10569819

OpenAlexW4386630636

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.